Graft-versus-Host Diseases: Developing Drugs, Biological Products, and Certain Devices for Prevention or Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 28, 2023
September 28, 2023
30eba576-b6ea-4536-918e-e634aefadcc4
Related Documents
Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Developing Drug and Biological Products in Oncology
Guidance DocumentJanuary 17, 2025Office of the Commissioner
Purpose and Content of Use-Related Risk Analyses for Drugs, Biological Products, and Combination Products
Guidance DocumentJuly 8, 2024Center for Drug Evaluation and Research
Osteoarthritis: Structural Endpoints for the Development of Drugs
Guidance DocumentAugust 23, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.